Table 3.
Tumour type | Ion AmpliSeq Cancer Panel copy number alterations | |||
---|---|---|---|---|
Gene | Gain (%) | Loss (%) | ||
Adenocarcinoma (n = 18) | R81 | 2 (11.1) | ||
EGFR | 2 (11.1) | - | ||
KRAS | 1 (5.5) | - | ||
ATM | 1 (5.5) | |||
MET | 1 (5.5) | - | ||
STK11 | 1 (5.5) | - | ||
Squamous cell carcinoma (n = 3) | Rs1 | - | 1 (33.3) | |
P/K3CA | 1 (33.3%) | - | ||
Adenosquamous carcinoma (n = 2) | ATM | - | 1 (50.0%) |
ion Torrent, Life Technologies, Thermo Fisher Scientific, Waltham, Massachusetts.